Crystal Geyser bottled water maker admits dumping arsenic in Californian water

Waste Management CEO: Going green was a ‘good economic decision’ Waste Management CEO Jim Fish discusses his company’s move to a natural gas-powered fleet and the company’s adoption of new technology for the future. The California company that produces Crystal Geyser Alpine Spring bottled water pleaded guilty to illegally dumping water that contained arsenic. Parent company CG Roxane LLC and two contracted firms […]

Read more

The real price of Occidental's 'costless' oil hedge

(Reuters) – In just 12 days, Occidental Petroleum Corp pulled off one of the biggest hedges against falling oil prices ever placed by a U.S. energy company. It characterized the transaction as “costless” but a Reuters review of regulatory filings, market data and interviews shows that’s not the whole story. The aim of the complex financial maneuver, the company said, […]

Read more

Rep. Brian Mast blasts Dems, media 'taking Iran's side': Soleimani died 'exactly the way' he should have

Rep. Mast blasts Pelosi, media for ‘covering’ for Soleimani Rep. Brian Mast, House Foreign Affairs Committee, criticizes Speaker Nancy Pelosi for passing the war powers resolution and the media for celebrating the death of Qassem Soleimani Veteran Rep. Brian Mast, R-Fla., said Friday that he couldn't be "more amazed" by those "taking Iran's side" after the rogue regime fired missiles at an […]

Read more

Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million

TOKYO (Reuters) – Astellas Pharma Inc (4503.T) has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month. Japan’s second biggest drugmaker by sales paid $120 million upfront for Xyphos and the rest will be milestone payments, the companies said in a […]

Read more

Britain gives Advent's $5 billion Cobham takeover the green light

LONDON (Reuters) – Britain has approved Advent International’s $5 billion purchase of defense company Cobham (COB.L) after the U.S. private equity group made commitments to address national security concerns. Business minister Andrea Leadsom had put the deal on hold to review the sale of air-to-air refueling equipment maker Cobham, which employs 10,000 people and also makes communications equipment for military […]

Read more

At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK…

The following are some of the companies that presented new/updated trial data of their investigational drug candidates at the 61st Annual Meeting of the American Society of Hematology (ASH) on Saturday. Watch out for these stocks on Monday… Axcella Health Inc. (AXLA) presented mechanistic data from preclinical studies of AXA4010, a hematology product candidate. AXA4010 is composed of a novel […]

Read more
1 2 3 28